CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Economic Times dated 20th December 2022

CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Economic Times dated 20th December 2022. The Economic Times.

Text The Economic Times_20-12-2022.pdf Download (324kB)

Abstract

CMFRI has signed an MoU with a private company dealing with health products for commercial production and marketing Cadalmin LivCure extract. A unique blend of 100% natural bioactive ingredients extracted from select seaweeds, the product is made using eco-friendly technology to improve liver health. It is the ninth nutraceutical developed by the CMFRI.

Item Type:	Article
Subjects:	CMFRI News Clippings
Divisions:	Library and Documentation Centre
Depositing User:	Mr. Augustine Sipson N A
Date Deposited:	26 Dec 2022 04:32
Last Modified:	26 Dec 2022 04:32
URI:	http://eprints.cmfri.org.in/id/eprint/16551

Actions (login required)

View Item